Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In a correspondence to Nature Medicine, a team of Oxford-led academics describe upcoming new guidelines to improve the reporting of early clinical stage (or first-with-human) evaluation of decision support systems driven by artificial intelligence.

Red light with silhouette of a man

As an increasing number of clinical decision-support systems driven by artificial intelligence progress from development to implementation, better guidance on the reporting of human factors (ergonomics) and early-stage clinical evaluation is needed.

Therefore, Dr Baptiste Vasey and Professor Peter McCulloch from the Nuffield Department of Surgical Sciences, together with a steering group of experts in the fields of machine learning, human factors, and guidelines development from Oxford University and other universities in the UK and abroad, aim to develop new guidelines to improve the reporting of the early-stage clinical evaluation of AI-based decision support systems.

“We are convinced that human clinicians should and will remain at the centre of patient care, and therefore aiming to improve the way in which AI-based clinical decision support systems are evaluated when used to enhance rather than replace human intelligence. A critical phase of this process is when such systems are assessed when first used by clinicians in real life settings,” says Dr Vasey.

The article outlines a Delphi process, comprising two rounds of experts’ feedback and one consensus meeting, and the rationale for the new Developmental and Exploratory Clinical Investigation of Decision support systems based on Artificial Intelligence (DECIDE-AI) guidelines being developed. The authors hope to address some of the important issues hindering the translation from in silico algorithm development to clinical impact.

Read the full story on the Nuffield Department of Surgical Sciences website

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.